Last 12 months
Inside the activity.
0 purchase rows · 18 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 10 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2020 Filed Jun 12, 2020 20:47 UTC |
Ling Geoffrey M.D.Director
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $7.18 | $0.00 |
DisclosureSEC source: 0001209191-20-036315 · doc4.xml · derivative · entry 1 Ling Geoffrey M.D. · CIK 0001800097 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2030-06-11 F1 · derivative.exercise_date: The option shall vest monthly over a period of 12 months commencing June 11, 2020. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 20:46 UTC |
LAWLOR AUGUSTINEDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $7.18 | $0.00 |
DisclosureSEC source: 0001209191-20-036313 · doc4.xml · derivative · entry 1 LAWLOR AUGUSTINE · CIK 0001262327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2030-06-11 F1 · derivative.exercise_date: The option shall vest monthly over a period of 12 months commencing June 11, 2020. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 20:44 UTC |
DESOUZA ERROL BDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $7.18 | $0.00 |
DisclosureSEC source: 0001209191-20-036311 · doc4.xml · derivative · entry 1 DESOUZA ERROL B · CIK 0001213895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2030-06-11 F1 · derivative.exercise_date: The option shall vest monthly over a period of 12 months commencing June 11, 2020. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 20:45 UTC |
Hunt AndreaDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $7.18 | $0.00 |
DisclosureSEC source: 0001209191-20-036312 · doc4.xml · derivative · entry 1 Hunt Andrea · CIK 0001720487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2030-06-11 F1 · derivative.exercise_date: The option shall vest monthly over a period of 12 months commencing June 11, 2020. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:44 UTC |
Williams EddieDirector
|
GrantCommon Stock | 2,717 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-023204 · doc4.xml · nonDerivative · entry 1 Williams Eddie · CIK 0001725276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,556 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:43 UTC |
TETLOW SHARONDirector
|
GrantCommon Stock | 1,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-023199 · doc4.xml · nonDerivative · entry 1 TETLOW SHARON · CIK 0001328565 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,932 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:41 UTC |
Ling Geoffrey M.D.Director
|
GrantCommon Stock | 1,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-023191 · doc4.xml · nonDerivative · entry 1 Ling Geoffrey M.D. · CIK 0001800097 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,932 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:40 UTC |
LAWLOR AUGUSTINEDirector
|
GrantCommon Stock | 4,934 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-023187 · doc4.xml · nonDerivative · entry 1 LAWLOR AUGUSTINE · CIK 0001262327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,542 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:37 UTC |
DESOUZA ERROL BDirector
|
GrantCommon Stock | 2,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-023174 · doc4.xml · nonDerivative · entry 1 DESOUZA ERROL B · CIK 0001213895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,498 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:39 UTC |
Hunt AndreaDirector
|
GrantCommon Stock | 1,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-023182 · doc4.xml · nonDerivative · entry 1 Hunt Andrea · CIK 0001720487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,799 F1 · shares: Represents shares of common stock received in lieu of fees. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 20:23 UTC |
Levy HowardChief Medical Officer
|
PurchaseCommon Stock | 2,500 | $4.05 | $10,131.50 |
DisclosureSEC source: 0001209191-20-019584 · doc4.xml · nonDerivative · entry 1 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Read SEC document |
| March 13, 2020 Filed Mar 13, 2020 22:56 UTC |
USMAN NASSIMDirector · President & CEO
|
PurchaseCommon Stock | 4,000 | $3.91 | $15,647.20 |
DisclosureSEC source: 0001209191-20-019040 · doc4.xml · nonDerivative · entry 1 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,010 F1 · price: Represents the weighted average purchase price per share. The shares were purchased at prices ranging from $3.87 to $3.92 per share. Full information regarding the number of shares purchased at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 13, 2020 Filed Mar 13, 2020 22:56 UTC |
Richard John PDirector
|
PurchaseCommon Stock | 2,500 | $3.98 | $9,950.00 |
DisclosureSEC source: 0001209191-20-019038 · doc4.xml · nonDerivative · entry 1 Richard John P · CIK 0001296528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,716 Read SEC document |
| March 13, 2020 Filed Mar 13, 2020 22:55 UTC |
Cai VeronicaController
|
PurchaseCommon Stock | 2,000 | $4.11 | $8,220.00 |
DisclosureSEC source: 0001209191-20-019037 · doc4.xml · nonDerivative · entry 1 Cai Veronica · CIK 0001801322 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,353 Read SEC document |
| March 04, 2020 Filed Mar 4, 2020 21:18 UTC |
Williams EddieDirector
|
PurchaseCommon Stock | 2,000 | $5.78 | $11,560.00 |
DisclosureSEC source: 0001209191-20-016061 · doc4.xml · nonDerivative · entry 1 Williams Eddie · CIK 0001725276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,839 Read SEC document |
| February 25, 2020 Filed Feb 25, 2020 21:21 UTC |
LAWLOR AUGUSTINEDirector
|
SaleCommon Stock | 69,401 | $6.10 | $423,505.72 |
DisclosureSEC source: 0001209191-20-012454 · doc4.xml · nonDerivative · entry 1 LAWLOR AUGUSTINE · CIK 0001262327 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By HealthCare Ventures VIII, L.P. Disclosed balance after: 0 F1 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $6.10 to $6.22 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. F2 · ownership.nature: HealthCare Ventures VIII, L.P. ("HCVVIII") is the registered owner of the securities. The Reporting Person is a managing director of HealthCare Partners VIII, LLC ("HCPVIII LLC"), the General Partner of HealthCare Partners VIII, L.P. ("HCPVIII"). HCPVIII is the General Partner of HCVVIII. The Reporting Person shares voting and investment power over the shares held by HCVVIII with each of Christopher Mirabelli, James Cavanaugh, John Littlechild and Harold Werner as managing directors of HCPVIII LLC. The Reporting Person disclaims beneficial ownership of those securities in which he does not have a pecuniary interest and this report shall not be deemed an admission that he is the beneficial owner of these securities for purposes of Section 16, except to the extent of his pecuniary interest therein. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 21:06 UTC |
Ling Geoffrey M.D.Director
|
PurchaseCommon Stock | 3,000 | $6.23 | $18,691.50 |
DisclosureSEC source: 0001209191-20-013392 · doc4.xml · nonDerivative · entry 1 Ling Geoffrey M.D. · CIK 0001800097 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 01:28 UTC |
USMAN NASSIMDirector · President & CEO
|
GrantCommon Stock | 430 | $6.23 | $2,678.90 |
DisclosureSEC source: 0001209191-20-009041 · doc4.xml · nonDerivative · entry 1 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,010 F1 · shares: Shares purchased under the Catalyst Biosciences, Inc. 2018 Employee Stock Purchase Plan ("ESPP") on February 10, 2020. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 01:28 UTC |
Levy HowardChief Medical Officer
|
GrantCommon Stock | 1,358 | $6.23 | $8,460.34 |
DisclosureSEC source: 0001209191-20-009040 · doc4.xml · nonDerivative · entry 1 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,358 F1 · shares: Shares purchased under the Catalyst Biosciences, Inc. 2018 Employee Stock Purchase Plan ("ESPP") on February 10, 2020. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 01:27 UTC |
Cai VeronicaController
|
GrantCommon Stock | 1,678 | $6.23 | $10,453.94 |
DisclosureSEC source: 0001209191-20-009039 · doc4.xml · nonDerivative · entry 1 Cai Veronica · CIK 0001801322 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,353 F1 · shares: Shares purchased under the Catalyst Biosciences, Inc. 2018 Employee Stock Purchase Plan ("ESPP") on February 10, 2020. Read SEC document |
| January 23, 2020 Filed Jan 27, 2020 19:00 UTC |
USMAN NASSIMDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 115,000 | $0.00 Strike: $6.85 | $0.00 |
DisclosureSEC source: 0001209191-20-004965 · doc4.xml · derivative · entry 1 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 115,000 shares Expires 2030-01-23 F1 · derivative.exercise_date: Award vests over a four (4) year period on each monthly anniversary commencing January 23, 2020. Read SEC document |
| January 23, 2020 Filed Jan 28, 2020 00:54 UTC |
Cai VeronicaController
|
GrantStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $6.85 | $0.00 |
DisclosureSEC source: 0001209191-20-005064 · doc4.xml · derivative · entry 1 Cai Veronica · CIK 0001801322 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2029-01-23 F1 · derivative.exercise_date: The grant vests monthly for four years from date of grant. Read SEC document |
| January 23, 2020 Filed Jan 27, 2020 19:00 UTC |
Levy HowardChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $6.85 | $0.00 |
DisclosureSEC source: 0001209191-20-004966 · doc4.xml · derivative · entry 1 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2030-01-23 F1 · derivative.exercise_date: Award vests over a four (4) year period on each monthly anniversary commencing January 23, 2020. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 21:06 UTC |
Ling Geoffrey M.D.Director
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $7.29 | $0.00 |
DisclosureSEC source: 0001209191-20-003937 · doc4.xml · derivative · entry 1 Ling Geoffrey M.D. · CIK 0001800097 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-01-15 F1 · derivative.exercise_date: The option shall vest monthly over a period of 36 months commencing January 15, 2020. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 21:07 UTC |
TETLOW SHARONDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $7.29 | $0.00 |
DisclosureSEC source: 0001209191-20-003942 · doc4.xml · derivative · entry 1 TETLOW SHARON · CIK 0001328565 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-01-15 F1 · derivative.exercise_date: The option shall vest monthly over a period of 36 months commencing January 15, 2020. Read SEC document |
| January 02, 2020 Filed Jan 2, 2020 21:46 UTC |
Williams EddieDirector
|
GrantCommon Stock | 1,743 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-000342 · doc4.xml · nonDerivative · entry 1 Williams Eddie · CIK 0001725276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,839 F1 · shares: Represents shares of stock received in lieu of fees. Read SEC document |
| January 02, 2020 Filed Jan 2, 2020 21:45 UTC |
LAWLOR AUGUSTINEDirector
|
GrantCommon Stock | 3,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-000340 · doc4.xml · nonDerivative · entry 1 LAWLOR AUGUSTINE · CIK 0001262327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,608 F1 · shares: Represents shares of stock received in lieu of fees. Read SEC document |
| January 02, 2020 Filed Jan 2, 2020 21:45 UTC |
Hunt AndreaDirector
|
GrantCommon Stock | 1,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-000337 · doc4.xml · nonDerivative · entry 1 Hunt Andrea · CIK 0001720487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,126 F1 · shares: Represents shares of stock received in lieu of fees. Read SEC document |
| January 02, 2020 Filed Jan 2, 2020 21:44 UTC |
DESOUZA ERROL BDirector
|
GrantCommon Stock | 1,835 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-000334 · doc4.xml · nonDerivative · entry 1 DESOUZA ERROL B · CIK 0001213895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,638 F1 · shares: Represents shares of stock received in lieu of fees. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 20:08 UTC |
LAWLOR AUGUSTINEDirector
|
GrantCommon Stock | 4,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-051620 · doc4.xml · nonDerivative · entry 1 LAWLOR AUGUSTINE · CIK 0001262327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,442 F1 · shares: Represents shares of stock received in lieu of fees. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 20:09 UTC |
Williams EddieDirector
|
GrantCommon Stock | 2,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-051626 · doc4.xml · nonDerivative · entry 1 Williams Eddie · CIK 0001725276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,096 F1 · shares: Represents shares of stock received in lieu of fees. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 20:07 UTC |
Hunt AndreaDirector
|
GrantCommon Stock | 1,489 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-051614 · doc4.xml · nonDerivative · entry 1 Hunt Andrea · CIK 0001720487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,053 F1 · shares: Represents shares of stock received in lieu of fees. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 20:06 UTC |
DESOUZA ERROL BDirector
|
GrantCommon Stock | 2,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-051609 · doc4.xml · nonDerivative · entry 1 DESOUZA ERROL B · CIK 0001213895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,803 F1 · shares: Represents shares of stock received in lieu of fees. Read SEC document |
| September 16, 2019 Filed Jan 28, 2020 00:54 UTC |
Cai VeronicaController
|
GrantStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $6.22 | $0.00 |
DisclosureSEC source: 0001209191-20-005063 · doc4.xml · derivative · entry 1 Cai Veronica · CIK 0001801322 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2029-09-16 F1 · derivative.exercise_date: Award vests over a four (4) year period on each monthly anniversary commencing September 3, 2019. Read SEC document |
| August 12, 2019 Filed Aug 12, 2019 20:22 UTC |
Payne FletcherChief Financial Officer
|
GrantCommon Stock | 1,180 | $6.51 | $7,681.80 |
DisclosureSEC source: 0001209191-19-045506 · doc4.xml · nonDerivative · entry 1 Payne Fletcher · CIK 0001650476 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,744 F1 · shares: Shares purchased under the Catalyst Biosciences, Inc. 2018 Employee Stock Purchase Plan ("ESPP") on August 12, 2019. Read SEC document |
| August 12, 2019 Filed Aug 12, 2019 20:21 UTC |
USMAN NASSIMDirector · President & CEO
|
GrantCommon Stock | 413 | $6.51 | $2,688.63 |
DisclosureSEC source: 0001209191-19-045504 · doc4.xml · nonDerivative · entry 1 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,580 F1 · shares: Shares purchased under the Catalyst Biosciences, Inc. 2018 Employee Stock Purchase Plan ("ESPP") on August 12, 2019. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:33 UTC |
DESOUZA ERROL BDirector
|
GrantCommon Stock | 1,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-040314 · doc4.xml · nonDerivative · entry 1 DESOUZA ERROL B · CIK 0001213895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,258 F1 · shares: Represents shares of stock received in lieu of fees. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:49 UTC |
Hunt AndreaDirector
|
GrantCommon Stock | 1,036 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-040358 · doc4.xml · nonDerivative · entry 1 Hunt Andrea · CIK 0001720487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,564 F1 · shares: Represents shares of stock received in lieu of fees. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:51 UTC |
Williams EddieDirector
|
GrantCommon Stock | 1,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-040363 · doc4.xml · nonDerivative · entry 1 Williams Eddie · CIK 0001725276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,678 F1 · shares: Represents shares of stock received in lieu of fees. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:50 UTC |
LAWLOR AUGUSTINEDirector
|
GrantCommon Stock | 2,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-040360 · doc4.xml · nonDerivative · entry 1 LAWLOR AUGUSTINE · CIK 0001262327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,051 F1 · shares: Represents shares of stock received in lieu of fees. Read SEC document |
| June 13, 2019 Filed Jun 18, 2019 01:17 UTC |
LAWLOR AUGUSTINEDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $7.46 | $0.00 |
DisclosureSEC source: 0001209191-19-037572 · doc4.xml · derivative · entry 1 LAWLOR AUGUSTINE · CIK 0001262327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2029-06-13 F1 · derivative.exercise_date: The option shall vest monthly over a period of 12 months commencing June 13, 2019. Read SEC document |
| June 13, 2019 Filed Jun 18, 2019 01:14 UTC |
Williams EddieDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $7.46 | $0.00 |
DisclosureSEC source: 0001209191-19-037571 · doc4.xml · derivative · entry 1 Williams Eddie · CIK 0001725276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2029-06-13 F1 · derivative.exercise_date: The option shall vest monthly over a period of 12 months commencing June 13, 2019. Read SEC document |
| June 13, 2019 Filed Jun 18, 2019 01:13 UTC |
Richard John PDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $7.46 | $0.00 |
DisclosureSEC source: 0001209191-19-037569 · doc4.xml · derivative · entry 1 Richard John P · CIK 0001296528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2029-06-13 F1 · derivative.exercise_date: The option shall vest monthly over a period of 12 months commencing June 13, 2019. Read SEC document |
| June 13, 2019 Filed Jun 18, 2019 01:08 UTC |
Hunt AndreaDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $7.46 | $0.00 |
DisclosureSEC source: 0001209191-19-037568 · doc4.xml · derivative · entry 1 Hunt Andrea · CIK 0001720487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2029-06-13 F1 · derivative.exercise_date: The option shall vest monthly over a period of 12 months commencing June 13, 2019. Read SEC document |
| June 13, 2019 Filed Jun 18, 2019 01:08 UTC |
DESOUZA ERROL BDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $7.46 | $0.00 |
DisclosureSEC source: 0001209191-19-037567 · doc4.xml · derivative · entry 1 DESOUZA ERROL B · CIK 0001213895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2029-06-13 F1 · derivative.exercise_date: The option shall vest monthly over a period of 12 months commencing June 13, 2019. Read SEC document |
| May 24, 2019 Filed May 28, 2019 13:45 UTC |
Richard John PDirector
|
PurchaseCommon Stock | 1,000 | $8.03 | $8,030.00 |
DisclosureSEC source: 0001209191-19-032871 · doc4.xml · nonDerivative · entry 1 Richard John P · CIK 0001296528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,216 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.02 to $8.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| May 21, 2019 Filed May 22, 2019 18:17 UTC |
USMAN NASSIMDirector · President & CEO
|
GiftCommon Stock | 4,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031970 · doc4.xml · nonDerivative · entry 3 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By The Usman Family Trust Disclosed balance after: 8,456 F1 · balance_after: On May 21, 2019, the reporting person transferred 4,400 directly owned shares of Company common stock to the Usman Family Trust of which the insider and his wife are trustees and beneficiaries. Read SEC document |
| May 21, 2019 Filed May 22, 2019 18:17 UTC |
USMAN NASSIMDirector · President & CEO
|
GiftCommon Stock | 4,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031970 · doc4.xml · nonDerivative · entry 2 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,167 F1 · balance_after: On May 21, 2019, the reporting person transferred 4,400 directly owned shares of Company common stock to the Usman Family Trust of which the insider and his wife are trustees and beneficiaries. Read SEC document |
| May 21, 2019 Filed May 22, 2019 18:17 UTC |
USMAN NASSIMDirector · President & CEO
|
Exercise / conversionCommon Stock | 4,400 | $4.63 | $20,372.00 |
DisclosureSEC source: 0001209191-19-031970 · doc4.xml · nonDerivative · entry 1 USMAN NASSIM · CIK 0001206872 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,567 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2019 Filed May 22, 2019 16:23 UTC |
Levy HowardChief Medical Officer
|
GiftCommon Stock | 16,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031947 · doc4.xml · nonDerivative · entry 2 Levy Howard · CIK 0001672333 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Howard and Gillian Levy Revocable Trust dated November 21, 1994 Disclosed balance after: 16,094 F1 · balance_after: On May 21, 2019, the reporting person transferred 16,094 directly owned shares of Company common stock to the Howard and Gillian Levy Revocable Trust dated November 21, 1994, of which the insider and his wife are trustees and beneficiaries. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.